Analysts Anticipate Nutrien Ltd (NTR) Will Post Quarterly Sales of $8.65 Billion

Equities research analysts expect Nutrien Ltd (NYSE:NTR) to post $8.65 billion in sales for the current quarter, Zacks reports. Three analysts have provided estimates for Nutrien’s earnings. The highest sales estimate is $8.74 billion and the lowest is $8.48 billion. Nutrien posted sales of $8.15 billion in the same quarter last year, which would indicate a positive year-over-year growth rate of 6.1%. The company is expected to report its next quarterly earnings results on Wednesday, August 7th.

According to Zacks, analysts expect that Nutrien will report full-year sales of $20.15 billion for the current financial year, with estimates ranging from $18.90 billion to $20.91 billion. For the next financial year, analysts anticipate that the company will post sales of $21.36 billion, with estimates ranging from $18.73 billion to $24.40 billion. Zacks Investment Research’s sales calculations are an average based on a survey of research firms that cover Nutrien.

Nutrien (NYSE:NTR) last issued its quarterly earnings data on Thursday, May 9th. The company reported $0.20 EPS for the quarter, missing the consensus estimate of $0.24 by ($0.04). Nutrien had a net margin of 18.41% and a return on equity of 12.95%. The business had revenue of $3.69 billion for the quarter, compared to analysts’ expectations of $3.71 billion. During the same quarter in the prior year, the company posted $0.16 EPS. The business’s revenue for the quarter was up .7% on a year-over-year basis.

Several brokerages have recently commented on NTR. Zacks Investment Research upgraded Nutrien from a “strong sell” rating to a “hold” rating in a report on Wednesday, April 10th. Raymond James reiterated a “strong-buy” rating and set a $70.00 price objective on shares of Nutrien in a report on Monday. Cowen reiterated an “outperform” rating and set a $66.00 price objective (down previously from $70.00) on shares of Nutrien in a report on Wednesday, March 6th. Finally, Barclays reiterated a “buy” rating on shares of Nutrien in a report on Sunday, February 10th. Six research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $61.50.

Shares of NTR traded down $0.26 during midday trading on Tuesday, hitting $49.83. 1,963,022 shares of the company’s stock traded hands, compared to its average volume of 1,640,942. Nutrien has a 1 year low of $43.96 and a 1 year high of $58.99. The firm has a market cap of $30.09 billion, a PE ratio of 18.52, a P/E/G ratio of 2.11 and a beta of 0.79.

The company also recently announced a quarterly dividend, which will be paid on Thursday, July 18th. Investors of record on Friday, June 28th will be paid a $0.43 dividend. The ex-dividend date is Thursday, June 27th. This represents a $1.72 dividend on an annualized basis and a yield of 3.45%. Nutrien’s dividend payout ratio (DPR) is 63.94%.

A number of hedge funds have recently modified their holdings of NTR. Bayesian Capital Management LP acquired a new stake in Nutrien during the 1st quarter worth about $390,000. Marshall Wace North America L.P. grew its position in Nutrien by 87.7% during the 1st quarter. Marshall Wace North America L.P. now owns 152,401 shares of the company’s stock worth $8,041,000 after purchasing an additional 71,188 shares during the period. Clal Insurance Enterprises Holdings Ltd grew its position in Nutrien by 69.3% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 846,383 shares of the company’s stock worth $44,928,000 after purchasing an additional 346,383 shares during the period. Moerus Capital Management LLC grew its position in Nutrien by 9.3% during the 1st quarter. Moerus Capital Management LLC now owns 642,206 shares of the company’s stock worth $33,883,000 after purchasing an additional 54,763 shares during the period. Finally, QCM Cayman Ltd. acquired a new stake in Nutrien during the 1st quarter worth about $222,000. Institutional investors own 66.63% of the company’s stock.

About Nutrien

Nutrien Ltd. produces and markets crop nutrients to agricultural, industrial, and feed customers worldwide. It operates in four segments: Retail, Potash, Nitrogen, and Phosphate and Sulfate. The company offers potash, nitrogen, phosphate, and sulfate products. It also distributes crop nutrients, crop protection products, seeds, and merchandise products through operating 1,700 retail locations.

Recommended Story: Resistance Level

Get a free copy of the Zacks research report on Nutrien (NTR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.